Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Other
Ratios

Avidity Biosciences (RNA) Preferred Shares Issued (2019 - 2020)

Avidity Biosciences (RNA) has disclosed Preferred Shares Issued for 2 consecutive years, with $2.2 million as the latest value for Q1 2020.

  • For the quarter ending Q1 2020, Preferred Shares Issued changed N/A year-over-year to $2.2 million, compared with a TTM value of $2.2 million through Dec 2020, changed N/A, and an annual FY2020 reading of $2.2 million, down 96.97% over the prior year.
  • Preferred Shares Issued was $2.2 million for Q1 2020 at Avidity Biosciences, down from $72.6 million in the prior quarter.
  • Across five years, Preferred Shares Issued topped out at $72.6 million in Q4 2019 and bottomed at $2.2 million in Q1 2020.